VALYSTR · Stock research
Listed on NYSE. What the market is pricing into Dr. Reddy's Laboratories Limited (RDY) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Drug Manufacturers - Specialty & Generic · market value about $11.9B · P/E 39.8 (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows